Wait a second!
More handpicked essays just for you.
More handpicked essays just for you.
Case study for parkinson's disease
Case study for parkinson's disease
Case study for parkinson's disease
Don’t take our word for it - see why 10 million students trust us with their essay needs.
Current research on Parkinson’s disease (PD) examines the effects of deteriorating dopaminergic neurons in the substantia nigra causing modifications in the basal ganglia circuitry1. The prevailing model behind this understanding is the classical model: activation of the direct pathway MSNs stimulates movement while activation of the indirect inhibits4. The idea is that motor deficits observed in PD are caused by an underactive direct pathway and an overactive indirect pathway. This research examined the classical model by studying the activity of specific basal ganglia structures using optogenetics to control the activity of direct and indirect pathway MSNs. The rationale for this study was to investigate this model in a controlled experimental …show more content…
This study promotes new research to identify mechanisms to modulate direct pathway circuitry and helps to identify effective therapeutic approaches for motor deficits2. The implication of the knowledge of basal ganglia circuitry in developing therapies could only be validated with further empirical analysis.
References
1. Blandini, F., Nappi, G., Tassorelli, C., & Martignoni, E. (2000). Functional changes of the basal ganglia circuitry in parkinson's disease. Progress in Neurobiology, 62(1), 63-88. doi:http://dx.doi.org/10.1016/S0301-0082(99)00067-2
2. Gerfen, C. R., Surmeier D.J. (2011) Modulation of striatal projection systems by dopamine. Annual Revenue Neurosci. 34:441-66. http://www.ncbi.nlm.nih.gov/pubmed/21469956
3. Kravitz, A. V., Freeze, B. S., Parker, P. R. L., Kay, K., Thwin, M. T., Deisseroth, K., & Kreitzer, A. C. (2010). Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry. Nature, S19-S23C. Retrieved from http://search.proquest.com/docview/756838430?accountid=14771
4. Obeso, J. A., Oroz, M. C., Rodriguez, M., Lanciego, J. L., Artieda, J., Gonzalo, N., & Olanow, C. W (2000). Pathophysiology of the basal ganglia in Parkinson’s disease. Trends Neurosci. 23(10), S8
...e in the brain to deliver electrical stimulation to targeted areas that control movement (mayoclinic.com, 2013).
The Role of Dopamine Receptors in Schizophrenia. Retrieved March 3, 2005, From Stanford University, Chemistry department web site, http://www.chem.csustan.edu/chem44x0/SJBR/Mann.htm Naheed, M., & Green, B. (2000). Focus on Clozapine. Retrieved February 7, 2005. From http://www.priory.com/focus14.htm Waddinton, J.L., & Buckley, P.F. (1996).
The cause of Tardive Dyskinesia has not been positively identified, but researchers do know that neuroleptic drugs change the way nerve impulses jump from the pre-synaptic neurons across a synapse to the post-synaptic neurons. (2). Such drugs prevent the neurotransmitter dopamine from reaching the brain, "directly impairing the function of the basal ganglia and the emotion-regulating limbic system and frontal lobes." (6)
Hypokinetic Dysarthria is a motor speech disorder that is often associated with Parkinson’s disease (PD). It can occur when there is interference in the basal ganglia control circuit. These disruptions can include “degenerative, vascular, traumatic, infectious, inflammatory, neoplastic, and toxic-metabolic diseases (Duffy, 2013, p. 176).” Damage to the basal ganglia control circuit results in reduced range of motion as well as the inability to inhibit involuntary movements. Hypokinetic dysarthria is most commonly caused by PD; a progressive, neurogenic disease that is characterized by tremor, rigidity, slowness of movement, and incoordination. Eighty-seven percent of hypokinetic dysarthria cases are associated with degenerative disease (Duffy, 2013).
Goldmann, David R., and David A. Horowitz. American College of Physicians Home Medical Guide to Parkinson's Disease. New York: Dorling Kindersley Pub., 2000. Print.
With more than 200,000 US cases per year, Parkinson’s disease has become a major part
Dopamine sends signals to other nerve cells in the brain, which regulates movement, motivation, emotion, and feelings of pleasure.
Research Updates. University of Rochester Medical Center. November 10, 2008. National Institutes of Health. February 6, 2009. < http://www.urmc.rochester.edu/neurology/nih-registry/research/index.cfm>.
Parkinson's is an idiopathic, multifactorial neurodegenerative disease that attacks neurotransmitters in the brain called dopamine. Dopamine is concentrated in a specific area of the brain called the substantia nigra. The neurotransmitter dopamine is a chemical that regulates muscle movement and emotion. Dopamine is responsible for relaying messages between the substantia nigra and other parts of the brain to control body movement. The death of these neurotransmitters affects the central nervous system. The most common symptoms are movement related, including shaking, rigidity, slowness of movement and difficulty with posture. Behavioral problems may arise as the disease progresses. Due to the loss of dopamine, Parkinson's patients will often experience depression and some compulsive behavior. In advanced stages of the disease dementia will sometimes occur. The implications of the disease on the anatomy and physiology of the respiratory and phonatory systems significantly control speech.
Most signs and symptoms of Parkinson disease correspond to one of three motor deficiencies: bradykinesia, akinesia, tremor, and rigidity. The first two qualities are usually present before tremor, but often attributed to aging by the patient and even the physician, and thus the disease is rarely diagnosed until tremor becomes evident much later. An average of 80% of the nigrostriatal neurons may have already degenerated by the time Parkinsonism is diagnosed, which complicates treatment (Fitzgerald, 130). Bra...
The path physiology of Parkinson’s disease is the pathogenesis if Parkinson disease is unknown. Epidemiologic data suggest genetic, viral, and environmental toxins as possible causes. Nigral and basal loss of neurons with depletion of dopamine, an inhibitory neurotransmitter, is the principal biochemical alteration in Parkinson disease. Symptoms in basal ganglia disorders result from an imbalance of dopaminergic (inhibitory) and cholinergic (excitatory) activity in the caudate and putamen of the basal ganglia.
716). Characteristic features of Parkinson's disease include “motor impairment (bradykinesia, rigidity, tremor, gait dysfunction, and postural instability), cognitive impairment (frontal lobe executive dysfunction), and mood disorders” (p. 716). Normally, motor performance depends on the interaction between automatic (unconscious) and volitional (cognitive) control of movement, however those with Parkinson's disease, experience an “early and preferential loss of dopamine in the caudal regions of the basal ganglia (dorsal regions in rodents), which leads to diminished automatic and increased cognitive control of movements that include frontal lobe circuitry” (p. 716). Consequently, those with Parkinson’s disease must sustain a larger cognitive load to execute either motor or cognitive tasks, such as working memory. In the past decade, increasing evidence has accrued for the role of exercise in the improvement of motor performance, which may help both the cognitive and automatic control of movement. Thus, exercise interventions can help those with Parkinson’s disease incorporate goal-based motor skill training, which then helps in engaging circuitry important in motor learning. Individuals with Parkinson's disease become cognitively engaged with the practice and acquiring of movements and skills that were formerly automatic and unconscious. In addition, aerobic exercise is also observed as important for improvement of blood flow and assistance of neuroplasticity in the elderly, which may also play a role in the improvement of behavioral function in those with Parkinson's disease. Petzinger et al. additionally states that exercise also uses goal-based training and aerobic activity which can improve “both cognitive and automatic
James Parkinson first discovered Parkinson's Disease in 1817. Parkinson's Disease is a common neurologic disorder for the elderly. It is a disorder of the brain characterized by shaking and difficulty with walking, movement, and coordination. This disease is associated with damage to a part of the brain that controls muscle movement. Parkinson's Disease is a chronic illness that is still being extensively studied.
Middleton, F.A., & Strick, P.L. (1994). Anatomical Evidence for Cerebellar and Basal Ganglia Involvement in Higher Cognitive Function. Science, 266, 458-461.
Hensler, J. G. (2006). Serotonergic modulation of the limbic system.Neuroscience & Biobehavioral Reviews, 30(2), 203-214.